INDIUM-111 PLATELET SURVIVAL STUDIES ON PLATELET CONCENTRATES (PCVSTORED FOR UP TO 14 DAYS

1987 ◽  
Author(s):  
S Holme ◽  
W A Heaton ◽  
P Hartman

The effect of extended storage on platelet in vitro and in vivo viability was investigated to determine the reliability and efficacy of Indium-111-oxine radiolabeling of long-term stored platelets. The fitness of various mathematical models for measurement of platelet survival and recovery was also evaluated.33 CPDA-1 PC were prepared and stored for various periods of time (see below) according to standard blood bank methods. The volume of the PC was adjusted to 65-75 mL to prevent pH fall with extended storage. After storage, samples were taken for in vitro assays and for radiolabeling witn Indium-111-oxine using standardized methods. None of the PC had pH<6.3. Afxer reinfusion of the labeled platelets, samples for measurement of radioactivity were taken at three hours and daily for seven days.The uptake {%) of Indium-111 and loss of platelets during the labeling showed no correlation with storage time; the means of the 33 studies were 71±8% and 35±6%, respectively. There was no significant correlation between the parameters and recovery or survival which suggests reliable labeling of nonviable platelets. Excellent fit of the survival data to the multiple hit gamma model was found forpall studies as determined by the coefficient of determination, r 2. The survival curves of platelets stored for one and five days were quite linear as shown by r2 ; with longer storage periods they became more exponential as shown by an increasingly better fit (r2 ) to the log model.Using the gamma model, both in vivo recovery and survival showed a progressive loss with increasing storage duration. This was less evident with the linear model. The loss of in vivo viability paralleled closely a decrease in the in vitro , parameters of platelet quality (discoid shape, hypotonic shock response, ATP content, and oxygen consumption) during storage.In conclusion, this study indicates that extended storage not only yields platelets with reduced recovery, but also platelets with shortened survival.

Author(s):  
M K Dewanjee ◽  
S A Rao ◽  
P Didisheim

Platelets have been labeled with a new, neutral, lipidsoluble metal-complex of Indium-111-tropolone (In-TPL). Unlike oxine, tropolone is soluble in isotonic saline. Oil/saline partition of In-111-oxine and In-TPL are 0.5 and 23.7 respectively. Platelet labeling with In-TPL was performed in both ACD-plasma and ACD-saline media within two hours' time. Increasing concentration of tropolone, citrate ion, and plasma proteins decreases plateletlabeling efficiency. Effects of pH, temperature, platelet concentration, and calcium ion concentration on platelet labeling were studied. In optimum platelet-labeling conditions, canine, rabbit, porcine, and human platelets have been labeled with a consistent labeling efficiency of 80-90%. The optimum labeling conditions are In-TPL in ACD- saline and ACD-plasma at tropolone concentration of 5 and 10 μg/ml respectively and 30 minutes’ incubation of platelets with the tracer at room temperature. A kit formulation for convenient routine preparation of In-111-labeled platelets has been developed. The function of the In-TPL- labeled platelets has been studied by their aggregability with adenosine diphosphate. The capacity of In-111-labeled platelets to aggregate in vitro does not correlate well with their ability to circulate in vivo. No adverse effect of In-TPL on platelets has been observed by studies of biodistribution, recovery, and platelet survival in dogs. Comparable mean platelet survival times of four repeated studies in five dogs were obtained in both ACD-saline and ACD-plasma. These results indicate that Indium-111 platelets labeled by tropolone carrier may be preferable to oxine carrier for studies of platelet survival, imaging sites of endothelial damage, and thrombus formation.


1977 ◽  
Author(s):  
S. Hanson ◽  
L.A. Harker

In vivo platelet reactions resulting in platelet utilization or release of constituents without platelet destruction have been studied in baboons by measuring isotopic disappearance of doubly labeled platelets using 51Cr as the cytoplasmic label to detect destruction and 14C-serotonin as a granular |abel to detect release. In 25 normal animals, the 14C-serotonin platelet survival (14C-SPS) was 6.0 days ± 0.2 compared with a Cr platelet survival (51Cr-PS) of 5.5 days ± 0.2, suggesting about 10% reutilization of the 14C label. Platelet labeling in vivo with 51C-serotonin showed that only 13% ± 2% of the injected activity became platelet bound; the remainder was cleared from the plasma within three hours. The platelets labeled in vivo survived normally (6.0 days ± 0.4). These results indicale that in vivo reutilization of serotonin is not extensive and that the process of labeling platelets with Cr in vitro does not appreciably shorten their survival in vivo. In other studies, animals with doubly labeled platelets received intravenous infusions of thrombin, ionophore R02-2985, arachidonic acid, ADP, collagen, plasmin, streptokinase, endotoxin, bovine factor VIII, and air bubbles. Thrombin or collagen infusions produced rapid, equivalent disappearance of both labels that correlated closely with decreases in platelet counts indicating that platelet destruction is not associated with reuptake of released C-serotonin by ambient circulating platelets. In contrast the infusions of R1I2-2985, plasmin or some studies with endotoxin induced selective disappearance of 51C-serotonin while 51Cr-PS was normal, reflecting platelet release in vivo without platelet destruction. With ADP, arachidonic acid, streptokinase and air bubbles platelets disappeared from the circulation transiently without loss of either label indicating transient platelet sequestration. We conclude that doubly labeled platelet survival studies are useful in characterizing platelet reactions and their pharmacologic alterations in vivo.


1979 ◽  
Vol 41 (03) ◽  
pp. 576-582
Author(s):  
A R Pomeroy

SummaryThe limitations of currently used in vitro assays of heparin have demonstrated the need for an in vivo method suitable for routine use.The in vivo method which is described in this paper uses, for each heparin preparation, four groups of five mice which are injected intravenously with heparin according to a “2 and 2 dose assay” procedure. The method is relatively rapid, requiring 3 to 4 hours to test five heparin preparations against a standard preparation of heparin. Levels of accuracy and precision acceptable for the requirements of the British Pharmacopoeia are obtained by combining the results of 3 to 4 assays of a heparin preparation.The similarity of results obtained the in vivo method and the in vitro method of the British Pharmacopoeia for heparin preparations of lung and mucosal origin validates this in vivo method and, conversely, demonstrates that the in vitro method of the British Pharmacopoeia gives a reliable estimation of the in vivo activity of heparin.


1975 ◽  
Vol 33 (03) ◽  
pp. 617-631 ◽  
Author(s):  
H. S Kingdon ◽  
R. L Lundblad ◽  
J. J Veltkamp ◽  
D. L Aronson

SummaryFactor IX concentrates manufactured from human plasma and intended for therapeutic infusion in man have been suspected for some time of being potentially thrombogenic. In the current studies, assays were carried out in vitro and in vivo for potentially thrombogenic materials. It was possible to rank the various materials tested according to the amount of thrombogenic material detected. For concentrates not containing heparin, there was substantial agreement between the in vivo and in vitro assays, with a coefficient of correlation of 0.77. There was no correlation between the assays for thrombogenicity and the antithrombin III content. We conclude that many presently available concentrates of Factor IX contain substantial amounts of potentially thrombogenic enzymes, and that this fact must be considered in arriving at the decision whether or not to use them therapeutically.


2018 ◽  
Vol 21 (3) ◽  
pp. 215-221
Author(s):  
Haroon Khan ◽  
Muhammad Zafar ◽  
Helena Den-Haan ◽  
Horacio Perez-Sanchez ◽  
Mohammad Amjad Kamal

Aim and Objective: Lipoxygenase (LOX) enzymes play an important role in the pathophysiology of several inflammatory and allergic diseases including bronchial asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, rheumatoid arthritis and chronic obstructive pulmonary disease. Inhibitors of the LOX are believed to be an ideal approach in the treatment of diseases caused by its over-expression. In this regard, several synthetic and natural agents are under investigation worldwide. Alkaloids are the most thoroughly investigated class of natural compounds with outstanding past in clinically useful drugs. In this article, we have discussed various alkaloids of plant origin that have already shown lipoxygenase inhibition in-vitro with possible correlation in in silico studies. Materials and Methods: Molecular docking studies were performed using MOE (Molecular Operating Environment) software. Among the ten reported LOX alkaloids inhibitors, derived from plant, compounds 4, 2, 3 and 1 showed excellent docking scores and receptor sensitivity. Result and Conclusion: These compounds already exhibited in vitro lipoxygenase inhibition and the MOE results strongly correlated with the experimental results. On the basis of these in vitro assays and computer aided results, we suggest that these compounds need further detail in vivo studies and clinical trial for the discovery of new more effective and safe lipoxygenase inhibitors. In conclusion, these results might be useful in the design of new and potential lipoxygenase (LOX) inhibitors.


2020 ◽  
Vol 16 ◽  
Author(s):  
Haicheng Liu ◽  
Yushi Futamura ◽  
Honghai Wu ◽  
Aki Ishiyama ◽  
Taotao Zhang ◽  
...  

Background: Malaria is one of the most devastating parasitic diseases, yet the discovery of antimalarial agents remains profoundly challenging. Very few new antimalarials have been developed in the past 50 years, while the emergence of drug-resistance continues to appear. Objective: This study focuses on the discovery, design, synthesis, and antimalarial evaluation of 3-cinnamamido-N-substituted benzamides. Method: In this study, a screening of our compound library was carried out against the multidrug-sensitive Plasmodium falciparum 3D7 strain. Derivatives of the hit were designed, synthesized and tested against P. falciparum 3D7 and the in vivo antimalarial activity of the most active compounds was evaluated using the method of Peters’ 4-day suppressive test. Results: The retrieved hit compound 1 containing a 3-cinnamamido-N-substituted benzamide skeleton showed moderate antimalarial activity (IC50 = 1.20 µM) for the first time. A series of derivatives were then synthesized through a simple four-step workflow, and half of them exhibited slightly better antimalarial effect than the precursor 1 during the subsequent in vitro assays. Additionally, compounds 11, 23, 30 and 31 displayed potent activity with IC50 values of approximately 0.1 µM, and weak cytotoxicity against mammalian cells. However, in vivo antimalarial activity is not effective which might be ascribed to the poor solubility of these compounds. Conclusion: In this study, phenotypic screen of our compound library resulted in the first report of 3-cinnamamide framework with antimalarial activity and 40 derivatives were then designed and synthesized. Subsequent structure-activity studies showed that compounds 11, 23, 30 and 31 exhibited the most potent and selective activity against P. falciparum 3D7 strain with IC50 values around 0.1 µM. Our work herein sets another example of phenotypic screen-based drug discovery, leading to potentially promising candidates of novel antimalarial agents once given further optimization.


2021 ◽  
Vol 9 (5) ◽  
pp. 1107
Author(s):  
Wonho Choi ◽  
Yoshihiro Yamaguchi ◽  
Ji-Young Park ◽  
Sang-Hyun Park ◽  
Hyeok-Won Lee ◽  
...  

Agrobacterium tumefaciens is a pathogen of various plants which transfers its own DNA (T-DNA) to the host plants. It is used for producing genetically modified plants with this ability. To control T-DNA transfer to the right place, toxin-antitoxin (TA) systems of A. tumefaciens were used to control the target site of transfer without any unintentional targeting. Here, we describe a toxin-antitoxin system, Atu0939 (mazE-at) and Atu0940 (mazF-at), in the chromosome of Agrobacterium tumefaciens. The toxin in the TA system has 33.3% identity and 45.5% similarity with MazF in Escherichia coli. The expression of MazF-at caused cell growth inhibition, while cells with MazF-at co-expressed with MazE-at grew normally. In vivo and in vitro assays revealed that MazF-at inhibited protein synthesis by decreasing the cellular mRNA stability. Moreover, the catalytic residue of MazF-at was determined to be the 24th glutamic acid using site-directed mutagenesis. From the results, we concluded that MazF-at is a type II toxin-antitoxin system and a ribosome-independent endoribonuclease. Here, we characterized a TA system in A. tumefaciens whose understanding might help to find its physiological function and to develop further applications.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Nan Jiang ◽  
Devendra H. Dusane ◽  
Jacob R. Brooks ◽  
Craig P. Delury ◽  
Sean S. Aiken ◽  
...  

AbstractThis study investigated the efficacy of a biphasic synthetic β-tricalcium phosphate/calcium sulfate (β-TCP/CS) bone graft substitute for compatibility with vancomycin (V) in combination with tobramycin (T) or gentamicin (G) evidenced by the duration of potency and the prevention and killing efficacies of P. aeruginosa (PAO1) and S. aureus (SAP231) biofilms in in vitro assays. Antibiotic loaded β-TCP/CS beads were compared with antibiotic loaded beads formed from a well characterized synthetic calcium sulfate (CS) bone void filler. β-TCP/CS antibiotic loaded showed antimicrobial potency against PAO1 in a repeated Kirby-Bauer like zone of inhibition assay for 6 days compared to 8 days for CS. However, both bead types showed potency against SAP231 for 40 days. Both formulations loaded with V + T completely prevented biofilm formation (CFU below detection limits) for the 3 days of the experiment with daily fresh inoculum challenges (P < 0.001). In addition, both antibiotic loaded materials and antibiotic combinations significantly reduced the bioburden of pre-grown biofilms by between 3 and 5 logs (P < 0.001) with V + G performing slightly better against PAO1 than V + T. Our data, combined with previous data on osteogenesis suggest that antibiotic loaded β-TCP/CS may have potential to stimulate osteogenesis through acting as a scaffold as well as simultaneously protecting against biofilm infection. Future in vivo experiments and clinical investigations are warranted to more comprehensively evaluate the use of β-TCP/CS in the management of orthopaedic infections.


Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1860
Author(s):  
Patricia Diez-Echave ◽  
Izaskun Martín-Cabrejas ◽  
José Garrido-Mesa ◽  
Susana Langa ◽  
Teresa Vezza ◽  
...  

Limosilactobacillus reuteri INIA P572 is a strain able to produce the antimicrobial compound reuterin in dairy products, exhibiting a protective effect against some food-borne pathogens. In this study, we investigated some probiotic properties of this strain such as resistance to gastrointestinal passage or to colonic conditions, reuterin production in a colonic environment, and immunomodulatory activity, using different in vitro and in vivo models. The results showed a high resistance of this strain to gastrointestinal conditions, as well as capacity to grow and produce reuterin in a human colonic model. Although the in vitro assays using the RAW 264.7 macrophage cell line did not demonstrate direct immunomodulatory properties, the in vivo assays using a Dextran Sulphate Sodium (DSS)-induced colitic mice model showed clear immunomodulatory and protective effects of this strain.


Sign in / Sign up

Export Citation Format

Share Document